Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sunil Kumar KB"'
Publikováno v:
Journal of Clinical Oncology. 38:e15614-e15614
e15614 Background: CLX-155 is a novel prodrug of 5-FU, developed by adding two acetyl groups (ester bond) and a caprylic acid moiety (amide bond) to 5'-DFCR ring structure. CLX-155 is designed to have a differentiated ADME profile, with improved safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65d1e266f7b80ed28ebb4b7fc0a7ac30
https://doi.org/10.1200/jco.2020.38.15_suppl.e15614
https://doi.org/10.1200/jco.2020.38.15_suppl.e15614
Autor:
Kandula, Mahesh1 kmahesh@cellixbio.com, Sunil Kumar, KB1 kbsunil@cellixbio.com, Palanichamy, Sivanesan1 sivanesanp@cellixbio.com, Rampal, Ashok1 rampala@cellixbio.com
Publikováno v:
International Immunopharmacology. Nov2016, Vol. 40, p443-451. 9p.
Autor:
Sunil Kumar KB; Department of Biochemistry, University of Kerala, Karaivattom, Trivandrum, India., Ankathil R, Devi KS
Publikováno v:
Human & experimental toxicology [Hum Exp Toxicol] 1993 Jul; Vol. 12 (4), pp. 285-8.